Loading...

TXMD THERAPEUTICSMD INC Delisting Actions 8-K Filing

THRP

TXMD

THERAPEUTICSMD INC

(TXMD)

2023 8-K

Financial Results

Accountant Change

Annual Meeting Results

Financial Results Announcement

Financial Statements

Financial Results

Annual Meeting Results

Q3 2024 Results

Annual Meeting Notice

Q2 Financial Results

Earnings Reports

Earnings Reports

Agreement with JZ Advisory ...

Earnings Report

Earnings Reports

Agreement with Rubric Capit...

Annual Meeting of Stockholders

Earnings Reports

Amendment and Consulting Ag...

Termination of Employment A...

Transaction with Mayne Pharma

External Links:

TherapeuticsMD received a deficiency letter from Nasdaq for not holding an annual meeting of stockholders within 12 months after its fiscal year ended.

AI Assistant

THERAPEUTICSMD INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.